Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP808646.RACKqBY7Jl5FI5ogQkmD-QD_Q9IvlGfQ8_zQPYkLsdUJM130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808646.RACKqBY7Jl5FI5ogQkmD-QD_Q9IvlGfQ8_zQPYkLsdUJM130_provenance.
• NP855883.RAVOsEGtgfO56VjVkA-s6XK6TZOCiQj3AUv3phot7hKmA130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855883.RAVOsEGtgfO56VjVkA-s6XK6TZOCiQj3AUv3phot7hKmA130_provenance.
• NP864397.RAZ18PrEJ9odznpva2xLtrnAWS1UNbjpgVRkszmTELvN8130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864397.RAZ18PrEJ9odznpva2xLtrnAWS1UNbjpgVRkszmTELvN8130_provenance.
• NP1135513.RAyXyncmOEE5CMcr0_WQ8uSaQVSgn5N_eL-KRz4DVZ0mE130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135513.RAyXyncmOEE5CMcr0_WQ8uSaQVSgn5N_eL-KRz4DVZ0mE130_provenance.
• NP1135514.RA_JyB5B42ziVipGPyiExmOxP6F9fvmdOIAVRLdAPy5uc130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135514.RA_JyB5B42ziVipGPyiExmOxP6F9fvmdOIAVRLdAPy5uc130_provenance.
• NP1135515.RA7sz3vTK2gbUj8KWeCpsAzL4eeeTUBK7FNlLwL43fr0o130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135515.RA7sz3vTK2gbUj8KWeCpsAzL4eeeTUBK7FNlLwL43fr0o130_provenance.
• NP221364.RAOihdANsyiUgR1qy_tTNHkVq2S9CG5uh5X6pWOVvxFLU130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221364.RAOihdANsyiUgR1qy_tTNHkVq2S9CG5uh5X6pWOVvxFLU130_provenance.
• NP608486.RAIR6tqPC5MCxWddOA1XP6SraJdPRNM1XvIy7FQq30tyU130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608486.RAIR6tqPC5MCxWddOA1XP6SraJdPRNM1XvIy7FQq30tyU130_provenance.
• NP1135511.RAX9RxgJ1X1ZJFB8VHBeYvJAi1IeqyDYmklKVoLXC02xY130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135511.RAX9RxgJ1X1ZJFB8VHBeYvJAi1IeqyDYmklKVoLXC02xY130_provenance.
• NP1135512.RAf37lSagq2MqOeRABkfVwbQD_qEv5LbApYdNoH7157mQ130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135512.RAf37lSagq2MqOeRABkfVwbQD_qEv5LbApYdNoH7157mQ130_provenance.
• NP1135516.RAfeJVhHxZ6OPuEHbd6ERRNsliu8ul32kYGlckFl7dt4Y130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135516.RAfeJVhHxZ6OPuEHbd6ERRNsliu8ul32kYGlckFl7dt4Y130_provenance.
• NP1135518.RAVtdcGOPJ3e_35t8UND6DXL4MYFIERUxXNHX79_flG_Q130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135518.RAVtdcGOPJ3e_35t8UND6DXL4MYFIERUxXNHX79_flG_Q130_provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1135519.RAOF2Z3yQW2A4mFZHwYZIBUjMq8EzpQvZ9E0z0eK7L0ig130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135519.RAOF2Z3yQW2A4mFZHwYZIBUjMq8EzpQvZ9E0z0eK7L0ig130_provenance.
• assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP916757.RAJDMxL_OFy9696acn7sC1qkcRR8BSo-WtkDx7BziS5GU130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916757.RAJDMxL_OFy9696acn7sC1qkcRR8BSo-WtkDx7BziS5GU130_provenance.
• NP864457.RApfxBLO0F4bXJJLF-qkioOsvzStv9wRvXfYUvvSJZtyQ130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864457.RApfxBLO0F4bXJJLF-qkioOsvzStv9wRvXfYUvvSJZtyQ130_provenance.
• NP898571.RAqGkxCKyWUbM-GAfvWLXAT9JZujicB8mChpIsFAkQVH4130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898571.RAqGkxCKyWUbM-GAfvWLXAT9JZujicB8mChpIsFAkQVH4130_provenance.
• NP855033.RApxZ0DRzMTgKrTWTh3bqWKVNKU82Z5gNCLwGjoOsq8D0130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855033.RApxZ0DRzMTgKrTWTh3bqWKVNKU82Z5gNCLwGjoOsq8D0130_provenance.
• NP1135517.RAudT3euIz8LhCYFATCTVWLdN630MQJOVZRp4rtnVcCEA130_assertion description "[The prevalence of hVISA among MRSA blood isolates was 13.7% (24/175) by PAP-AUC method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135517.RAudT3euIz8LhCYFATCTVWLdN630MQJOVZRp4rtnVcCEA130_provenance.